This study aims to investigate and compare High Dose Rate Brachytherapy (HDR-BT) with Helical Tomotherapy (HT) treatment plans. The focus is on small target volumes near radiation-sensitive organs in the ocular region, to evaluate the advantages of these techniques in treating skin cancer. This retrospective observational analysis included patients who underwent skin cancer HDR-BT Freiburg flap treatment between 2019 and 2023. An expert radiation oncologist contoured the planning target volumes (PTVs) and marked their visible extension with a radio-opaque tin wire. Each patient had two treatment plans: an individually shaped HDR-BT surface mold and an HT calculation used specifically for this study. Quality assurance of treatment plan was performed in both HDR-BT and HT. The plans were then compared using organ at risk (OAR) maximum doses and the conformity index CI. Radiation oncologists assessed their quality using their routine workflow evaluation plan. Twelve patients were selected for the inclusion in this study. HT provided more consistent target coverage than HDR-BT, with a statistically significant difference (p < 0.05) at t-test. HT showed higher CIs and maximum dose for the optic nerve, optic chiasm, and lens in the homolateral part. Radiation oncologists preferred the overall quality of HT treatment due to its superior PTV coverage, especially for convex surfaces, while maintaining effective OAR sparing. HDR-BT is preferred when concave surfaces are present. HT offers more conformal treatment, although some OAR parameters are statistically significantly better with HDR-BT, which may also be superior for complex geometries.
The DirectDensity® CT reconstruction algorithm provides a reconstruction approach independent of the tube voltage, directly reconstructing the CT projection data into CT numbers related to the electron densities of the materials. This work examines the efficacy of DirectDensity® in the treatment planning process with both tissues and metallic materials. CT scans of a Cheese phantom were acquired at 80, 100, 120 and 140 kVp and reconstructed with different algorithms. Calibration curves were built for each kVp and reconstruction technique. To evaluate the flexibility of the DirectDensity® in dose calculations, a prostate cancer treatment plan was simulated on phantom images with and without metal inserts. Moreover, the robustness of the algorithm was tested by simulating a possible error in the selection of the calibration curve. As expected, the calibration curves related to DirectDensity® showed a tube voltage dependence only for densities above 1.82 g/cm3. The maximum percentage differences in dose distributions comparations never exceeded the 3% of tolerance and the 3D gamma analysis always returned indices greater than 90%. The results suggest that the DD reconstruction algorithm can be employed in most clinical cases and allows for a personalized radiotherapy cancer treatment workflow, maintaining its robustness and simplicity.
18 March 2024 in The European Physical Journal Plus
The increasing use of 177Lu-labelled agents for targeted radionuclide cancer therapy highlights the radiation protection challenges in the management of radioactive waste due to 177mLu impurities. To ensure safe disposal, compliance with clearance criteria must be verified using calibrated systems, such as Hyper Pure Germanium (HPGe) spectrometers. This work aims to validate a customized GEANT4 model of our HPGe system in Marinelli beaker geometry to propose an operational approach properly quantifying 177Lu and 177mLu in waste samples. The system's efficiency curve was calculated by modelling gamma sources in the energy range of interest and validated by spectra measurements of 177Lu and 99mTc sources. Correction factors accounting for true coincidence summing (TCS) effect were simulated for 177Lu, 177mLu and 99mTc and they were applied to the spectrum measurement of a waste sample model with known activities of 177Lu and 177mLu. Thus, an operational approach for activities quantification was tested comparing the results with the nominal values. No significant differences were observed between simulated and measured efficiency values. TCS correction factors are significant only for 177mLu (1.6 at 112.95 keV and 204.11 keV). Eventually, the proposed framework to quantify 177Lu in a waste sample allowed to estimate the 177Lu and 177mLu component activities within a maximum 16% uncertainty. Results show that the HPGe model could be a powerful resource for a wide range of applications in daily clinical routine and it could be used to build a simple quality assurance program to monitor the detector response constancy in time.